[HTML][HTML] Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020

HK Jung, SJ Kang, YC Lee, HJ Yang, SY Park… - Gut and liver, 2021 - ncbi.nlm.nih.gov
Helicobacter pylori infection is one of the most common infectious diseases worldwide.
Although the prevalence of H. pylori is gradually decreasing, approximately half of the …

rifabutin in the treatment of refractory Helicobacter pylori infection

JP Gisbert, X Calvet - Alimentary pharmacology & therapeutics, 2012 - Wiley Online Library
Aliment Pharmacol Ther 2012; 35: 209–221 Summary Background Even with the current
most effective treatment regimens, a relevant proportion of patients will fail to eradicate …

ACG clinical guideline: treatment of Helicobacter pylori infection

WD Chey, GI Leontiadis, CW Howden… - Official journal of the …, 2017 - journals.lww.com
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review

JP Gisbert - Pathogens, 2020 - mdpi.com
Nowadays, apart from having to know first-line Helicobacter pylori eradication regimens
well, we must also be prepared to face treatment failures. The aim of this review is to …

[HTML][HTML] “Rescue” regimens after Helicobacter pylori treatment failure

JP Gisbert - World journal of gastroenterology: WJG, 2008 - ncbi.nlm.nih.gov
Helicobacter pylori (H pylori) infection is the main cause of gastritis, gastroduodenal ulcer
disease, and gastric cancer. After more than 20 years of experience in H pylori treatment, in …

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

OP Nyssen, D Vaira, IM Saracino, G Fiorini… - Journal of Clinical …, 2022 - mdpi.com
Background: First-line Helicobacter pylori (H. pylori) treatments have been relatively well
evaluated; however, it remains necessary to identify the most effective rescue treatments …

Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

JP Gisbert, M Castro‐Fernandez… - Alimentary …, 2012 - Wiley Online Library
Background In some cases, H elicobacter pylori infection persists even after three
eradication treatments. Aim To evaluate the efficacy of an empirical fourth‐line rescue …

The effectiveness of rifabutin triple therapy for patients with difficult‐to‐eradicate Helicobacter pylori in clinical practice

D Van der Poorten, PH Katelaris - Alimentary pharmacology & …, 2007 - Wiley Online Library
Background Failure of first line and subsequent Helicobacter pylori eradication therapy is a
significant problem and alternative treatments are few. Aims To evaluate the efficacy of a …

Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen

K Inokuchi, H Mori, J Matsuzaki, K Hirata… - …, 2022 - Wiley Online Library
Background Rifabutin‐based regimens are used as rescue therapy for refractory
Helicobacter pylori infection; however, the duration for which treatment is required and side …

Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third‐Line Treatment of Helicobacter pylori Infection: Two Pilot …

AF Ciccaglione, R Tavani, L Grossi, L Cellini… - …, 2016 - Wiley Online Library
Aim To evaluate the therapeutic gain of the addition of bismuth to a rifabutin containing triple
therapy with amoxicillin and pantoprazole at standard dosages for the treatment of third‐line …